CD4 and deltaretrovirus infections: While the exact mechanism contributing to worse survival outcomes is still under debate, data have suggested that CD4+ T cell dysfunction mediated by HTLV infection may contribute to defects in anti-tumor responses (Höllsberg et al., 1992; Mueller et al., 1996; Sibon et al., 2006).